Cholinesterase inhibitors may treat Neuropsychiatric symptoms in Alzheimers and Parkinson's Disease patients: JAMA Niveditha Subramani6 July 2023 9:30 AM ISTRecently Neuropsychiatric symptoms such as depression, apathy, aggression, and psychosis are now recognized as core features of Alzheimer's disease...
Investigational drug acoziborole promising for sleeping sickness elimination in Africa: Lancet Dr. Kamal Kant Kohli1 Dec 2022 8:00 PM ISTSwitzerland: A Phase II/III study, published in The Lancet Infectious Diseases, investigating the safety and efficacy of a single-dose acoziborole led...
ADHD drugs might also treat Alzheimer's disease Isra Zaman8 July 2022 9:30 AM ISTThere is "good evidence" that drugs to treat attention deficit hyperactivity disorder (ADHD) might also successfully treat key aspects of...
Bartonella infection tied to psychiatric symptoms and skin lesions: Study Hina Zahid26 Dec 2020 9:45 AM ISTBartonella bacteria are increasingly recognized as an emerging infectious disease threat.Researchers at North Carolina State University have found...
Montelukast must have boxed warning for neuropsychiatric events risk insists FDA Dr. Kamal Kant Kohli5 March 2020 7:33 AM ISTThe U.S. Food and Drug Administration has issued instructions to manufacturers of montelukas to strengthen an existing warning about the risk of...
